• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗心肌梗死后患者药物治疗依从性评估。新的自我报告问卷有一席之地吗?

Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires?

机构信息

a Department of Health Promotion , Collegium Medicum, Nicolaus Copernicus University , Bydgoszcz , Poland.

b Department of Cardiology and Internal Diseases , Collegium Medicum, Nicolaus Copernicus University , Bydgoszcz , Poland.

出版信息

Curr Med Res Opin. 2019 Feb;35(2):341-349. doi: 10.1080/03007995.2018.1510385. Epub 2018 Sep 13.

DOI:10.1080/03007995.2018.1510385
PMID:30091642
Abstract

INTRODUCTION

Non-adherence to medication regimen after myocardial infarction (MI) leads to increased morbidity and mortality and generates additional cost to the healthcare system.

OBJECTIVES

The aim of this systematic review was to critically discuss assessment methods of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention and the possible application of a new self-reported questionnaire.

METHODS

A systematic investigation of all published literature was conducted to minimize the risk of bias. A database search (PubMed, CENTRAL and Google Scholar databases) from January 1998 through December 2017.

RESULTS

Adequate assessment of patient adherence to treatment is necessary to understand the potential for adverse outcomes. Methods developed for adherence evaluation are classified as subjective and objective or as direct and indirect. Direct, objective measures reflect pharmacokinetics and include measurement of the drug or its metabolite concentration, evaluation of the presence of biological markers given with the drug and direct observation of patients' medication-taking behavior. Several indirect, objective methods are based on evaluation of the availability of prescribed medications assuming that medication is taken exactly as prescribed. Assessment of the effectiveness of treatment, both at the pharmacodynamic and clinical level, indirectly but objectively reflects adherence to treatment. Subjective methods, including patient-kept diaries, patient interviews and self-reported questionnaires, due to their simplicity, real-time feedback and low cost, are often used for adherence evaluation in clinical practice.

CONCLUSIONS

In spite of the availability, convenience and variety of methods, measuring adherence still remains a real challenge. Using a well designed questionnaire provides an opportunity to identify patients at increased risk of non-adherence and the obstacles impeding implementation of the treatment plan, allowing implementation of tailored interventions in order to improve patient medication-taking behavior.

摘要

简介

心肌梗死后不遵守药物治疗方案会导致发病率和死亡率增加,并给医疗保健系统带来额外的成本。

目的

本系统评价的目的是批判性地讨论经皮冠状动脉介入治疗后心肌梗死患者药物治疗依从性的评估方法,以及新的自我报告问卷的可能应用。

方法

为了最大限度地降低偏倚风险,对所有已发表的文献进行了系统调查。从 1998 年 1 月至 2017 年 12 月,在 PubMed、CENTRAL 和 Google Scholar 数据库中进行了数据库搜索。

结果

为了了解不良结局的潜在可能性,对患者治疗依从性进行充分评估是必要的。为评估依从性而制定的方法分为主观和客观或直接和间接。直接、客观的措施反映了药物代谢动力学,包括测量药物或其代谢物的浓度、评估药物伴随生物标志物的存在以及直接观察患者的用药行为。几种间接、客观的方法基于评估所规定药物的可用性,假设药物的服用完全符合规定。治疗效果的评估,无论是在药效学还是临床水平上,都间接但客观地反映了对治疗的依从性。由于其简单性、实时反馈和低成本,主观方法,包括患者保存的日记、患者访谈和自我报告问卷,常用于临床实践中的依从性评估。

结论

尽管有多种方法,包括可用性、便利性和多样性,但测量依从性仍然是一个真正的挑战。使用设计良好的问卷可以有机会确定药物治疗依从性差的患者以及阻碍治疗计划实施的障碍,从而实施有针对性的干预措施,以改善患者的服药行为。

相似文献

1
Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires?经皮冠状动脉介入治疗心肌梗死后患者药物治疗依从性评估。新的自我报告问卷有一席之地吗?
Curr Med Res Opin. 2019 Feb;35(2):341-349. doi: 10.1080/03007995.2018.1510385. Epub 2018 Sep 13.
2
Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials.坚持使用P2Y12受体抑制剂进行抗血小板治疗。我们能做些什么来改善它?一项随机试验的系统评价。
Curr Med Res Opin. 2016 Aug;32(8):1441-51. doi: 10.1080/03007995.2016.1182901. Epub 2016 May 25.
3
Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective.初次经皮冠状动脉介入治疗后坚持药物治疗方案的挑战:患者视角。
Int J Nurs Stud. 2018 Dec;88:16-24. doi: 10.1016/j.ijnurstu.2018.07.013. Epub 2018 Jul 26.
4
Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome).经皮冠状动脉介入治疗的急性心肌梗死患者中,二磷酸腺苷受体抑制剂的早期停用:来自TRANSLATE-ACS研究(二磷酸腺苷受体抑制剂治疗:急性冠状动脉综合征后治疗模式和事件的纵向评估)的见解
Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.115.003602.
5
Impact of left ventricular ejection fraction and medication adherence on major adverse cardiac events during the first year after successful primary percutaneous coronary interventions.成功进行直接经皮冠状动脉介入治疗后第一年,左心室射血分数和药物依从性对主要不良心脏事件的影响。
J Clin Nurs. 2016 Apr;25(7-8):1101-11. doi: 10.1111/jocn.13109. Epub 2015 Dec 27.
6
Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction.双重符合医疗保险-医疗补助资格的成年人心肌梗死的治疗、结果和药物治疗方案的依从性。
JAMA Cardiol. 2016 Oct 1;1(7):787-794. doi: 10.1001/jamacardio.2016.2724.
7
The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.门诊护理环境中成人癌症患者接受治疗性患者教育对口服抗癌药物依从性的有效性:一项系统综述
JBI Database System Rev Implement Rep. 2015 Jun 12;13(5):244-92. doi: 10.11124/jbisrir-2015-2057.
8
Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction.心肌梗死后抗血小板治疗依从性评估中的差异。
Pharmacology. 2015;95(1-2):50-8. doi: 10.1159/000371392. Epub 2015 Jan 15.
9
The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.一项针对社区药房患者定制干预方案以提高抗高血压药物依从性的(成本-)效益分析:一项随机对照试验的研究方案
Trials. 2017 Jan 19;18(1):29. doi: 10.1186/s13063-016-1696-3.
10
Long-term medication adherence in patients with ST-elevation myocardial infarction and primary percutaneous coronary intervention.ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后的长期药物依从性。
Eur J Prev Cardiol. 2015 Jul;22(7):890-8. doi: 10.1177/2047487314540385. Epub 2014 Jun 17.

引用本文的文献

1
High On-Treatment Platelet Reactivity as a Tool for Risk Stratification in STEMI Patients.高治疗期血小板反应性作为ST段抬高型心肌梗死患者风险分层的工具
J Clin Med. 2025 Aug 26;14(17):6026. doi: 10.3390/jcm14176026.
2
Capsule robots for the monitoring, diagnosis, and treatment of intestinal diseases.用于肠道疾病监测、诊断和治疗的胶囊机器人。
Mater Today Bio. 2024 Oct 9;29:101294. doi: 10.1016/j.mtbio.2024.101294. eCollection 2024 Dec.
3
Quality of life and functioning in chronic disease - what to assess in heart failure patients.
慢性病患者的生活质量与功能——心力衰竭患者需评估的内容
Cardiol J. 2024;31(3):502-503. doi: 10.5603/cj.97859. Epub 2024 May 22.
4
High platelet adrenergic activity and concomitant activation of the pituitary/medullar axis as alarming laboratory parameters in ACS survivors-the STRESS-AMI study.高血小板肾上腺素能活性及垂体/髓质轴的伴随激活作为急性冠脉综合征幸存者的警示实验室参数——应激性心肌梗死研究
Front Cardiovasc Med. 2024 Feb 21;11:1338066. doi: 10.3389/fcvm.2024.1338066. eCollection 2024.
5
The use of the Capability-Opportunity- Motivation Behavior (COM-B) model to identify barriers to medication adherence and the application of mobile health technology in adults with coronary heart disease: A qualitative study.运用能力-机会-动机行为(COM-B)模型识别冠心病成年患者药物依从性的障碍以及移动健康技术的应用:一项定性研究。
PEC Innov. 2023 Sep 7;3:100209. doi: 10.1016/j.pecinn.2023.100209. eCollection 2023 Dec 15.
6
The Association Between Medication Non-Adherence and Early and Late Readmission Rates for Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者用药依从性与早期和晚期再入院率之间的关联
Int J Gen Med. 2022 Aug 25;15:6791-6799. doi: 10.2147/IJGM.S376926. eCollection 2022.
7
Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients.钠-葡萄糖协同转运蛋白2抑制剂:心力衰竭患者的一种新型多向治疗选择。
Cardiol J. 2023;30(1):143-149. doi: 10.5603/CJ.a2021.0133. Epub 2021 Oct 28.
8
A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study.一种新的基于替格瑞洛的急性冠脉综合征后抗血小板治疗降级方法。一项随机、双盲、安慰剂对照、研究者发起、多中心临床研究的原理。
Cardiol J. 2021;28(4):607-614. doi: 10.5603/CJ.a2021.0056. Epub 2021 Jun 7.
9
Therapy Discontinuation after Myocardial Infarction.心肌梗死后的治疗中断
J Clin Med. 2020 Dec 19;9(12):4109. doi: 10.3390/jcm9124109.
10
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients.替格瑞洛和普拉格雷可独立预测 ACS 患者长期生存改善。
Eur J Clin Invest. 2020 Nov;50(11):e13304. doi: 10.1111/eci.13304. Epub 2020 Sep 9.